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Abstract
Purpose: The purpose of this study was to investigate the utility of telepractice for delivering 
flow phonation exercises to persons with primary muscle tension dysphonia (MTD). Method: 
Fourteen participants with a diagnosis of primary MTD participated, 7 on site and 7 at remote 
locations. Each participant received 12 treatment sessions across 6 weeks. Treatment consisted 
of flow phonation voice therapy exercises. Auditory–perceptual, acoustic, aerodynamic, and 
quality-of-life measures were taken before and after treatment. Results: Perceptual and quality-
of-life measures were significantly better posttreatment and were statistically equivalent across 
groups. Acoustic and aerodynamic measures improved in both groups, but changes did not 
reach statistical significance. Results for the 2 service delivery groups were comparable, with no 
significant differences observed for perceptual and quality-of-life measures. Conclusions: 
Although the American Speech-Language-Hearing Association supports the use of telepractice 
for speech-language pathology services, evidence for the use of telepractice for providing 
behavioral treatment to patients with MTD has been lacking. The results of this study indicate 
that flow phonation exercises can be successfully used for patients with MTD using telepractice.
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The American Speech-Language-Hearing Association(ASHA; 2002) defines telepractice as the applicationof telecommunications technology to delivery of
professional services at a distance by linking clinician to cli-
ent, or clinician to clinician, for assessment, intervention,
and/or consultation. Moreover, ASHA emphasizes that tele-
practice is an appropriate model of service delivery for the
professions of speech-language pathology and audiology
and may be used to overcome barriers of access to services
caused by distance, unavailability of specialists and/or sub-
specialists, and impaired mobility. With the growth of popu-
lations requiring services and a relative dearth of service
providers in rural areas, telepractice is becoming morecommonplace in health-care service delivery. Research ev-
idence to support the efficacy of the use of telepractice is
growing but not extensive. It is important to define the
utility of telepractice in general, but it is also important
to focus on specific types of treatments for specific types
of patients. Telepractice may be more effective for one
population or one type of treatment than another. In this
study, we investigated the use of a flow phonation voice
treatment method for individuals with primary muscle ten-
sion dysphonia (MTD), delivered through telepractice.
Telepractice and Voice Treatment
There have been reports of successful outcomes with
delivery of voice treatment using telepractice. Mashima,
Birkmire-Peters, Holtel, and Syms (1999) randomly assigned
10 patients to either a control condition (n = 4), in which
therapy was conducted on site, or to an experimental con-
dition (n = 6), in which the therapy was offered through
telepractice. Patients were assessed using laryngoscopy, per-
ceptual and acoustic voice measures, and patient-reported
treatment outcomes. The results indicated that posttreatment
recordings on all four measures were rated better than
pretreatment recordings for the telepractice group, whereas
voice recordings of only four of the six participants in the
in-person group were rated as improved posttreatment. The
findings were reported as preliminary results in an article
addressing telepractice principles for speech-language
pathology. Details about the voice therapy approaches used
were not provided.
Extending upon their previous work, Mashima et al.
(2003) compared voice treatment delivered in person and
through telepractice for two groups of individuals with la-
ryngeal conditions, including nodules, vocal fold paralysis,
hyperfunction, and edema. Telepractice and in-person groups
consisted of 23 and 28 individuals, respectively. Participants
were assigned to the groups randomly but were matched for
diagnostic category. Patient-specific treatment approaches
were followed. Depending on the vocal pathology, facilitating
voice treatment approaches (Boone, McFarlane, Von Berg,
& Zraick, 2013)—that is, focus, pitch adjustment, yawn–sigh,
easy onset, open-mouth approach, pitch inflections, and
chant talk—“confidential voice” (Colton & Casper, 1990)
or vocal function exercises (Stemple, Glaze, & Gerdeman,
2000) were used. Vocal hygiene education was provided to
all participants in both groups as well. Perceptual and acous-
tic voice assessments, patient satisfaction, and laryngoscopic
images were compared before and after treatment for both
groups. Posttreatment gains were shown in both groups and
were comparable, implying that voice treatment delivered
through telepractice was as effective as in-person treatment
for these participants.
Tindall, Huebner, Stemple, and Kleinert (2008) ex-
amined voice treatment outcomes delivered through tele-
practice for a group of individuals with Parkinson’s disease
and compared those from a previously reported study (Ramig,
Sapir, Fox, & Countryman, 2001) on individuals who were
treated in in-person sessions. Twenty-four individuals diag-
nosed with idiopathic Parkinson’s disease were provided the
Lee Silverman Voice treatment (LSVT) approach through
video phone calling. Significant improvement in vocal in-
tensity post therapy was reported, and the results were in
good agreement with those obtained by Ramig et al. (2001)
for in-person therapy.
Constantinescu et al. (2010a, 2010b, 2011) reported a
series of studies demonstrating the utility of telepractice in
voice assessment and treatment of individuals with Parkinson’s
disease. In their first study (Constantinescu et al., 2010a),
the authors examined the validity of assessing speech and
voice in 61 individuals with Parkinson’s disease in tele-
practice versus in-person sessions and reported comparable
results for vocal sound pressure level, phonation time, pitch
range, sentence intelligibility, and communication efficiency
in reading. Furthermore, the authors reported a case report
(Constantinescu et al., 2010b) validating the utility of online
delivery of LSVT. A patient with idiopathic Parkinson’s
disease was treated remotely for voice and speech impair-
ments using LSVT and showed improvements in sound
pressure levels, duration of sustained vowel production,
vocal quality, and intelligibility, as well as high satisfaction
with the treatment. The authors also reported successful
delivery of the LSVT in 34 participants with Parkinson’sdisease and hypokinetic dysarthria (Constantinescu et al.,
2011). They reported noninferiority of the online delivery
as compared to in-person delivery on the basis of a non-
inferiority analysis of the data; that is, effects of the online
delivery were not worse than the effects of in-person delivery
by more than a specified margin.
The aforementioned studies suggest that voice treat-
ment delivered through telepractice can be as effective as
treatment delivered in person. Although the primary goal
of the aforementioned studies by Mashima and colleagues
(1999, 2003) was to investigate the efficacy of telepractice,
control for participant homogeneity would add value to re-
search related to voice therapy and telepractice. Research
in the online delivery of LSVT to individuals with Parkinson’s
disease has been shown to be useful. However, research
demonstrating the efficacy of LSVT for improving vocal
hypofunction in patients with Parkinson’s using telepractice
does not essentially mean that other behavioral voice thera-
pies, such as therapies for vocal hyperfunction, can be de-
livered successfully via telepractice. It would be useful to
establish the efficacy of various types of treatments used with
telepractice before advocating routine clinical use.
MTD
MTD has been defined as a behaviorally based voice
disorder (Morrison & Rammage, 1993) characterized by
“imbalanced” laryngeal or perilaryngeal muscle activity that
putatively involves vocal fold hyperfunction, laryngeal con-
striction, or bowing (Altman, Atkinson, & Lazarus, 2005;
Mathieson et al., 2009). MTD could be primary or secondary.
Primary MTD is defined as a voice problem in the absence
of known concurrent structural or neurologic abnormalities
(Awan & Roy, 2009; Roy, 2003; Verdolini, Rosen, & Branski,
2006). Secondary MTD is defined as a response to organic
conditions and may affect voice quality, pitch, or loudness
(Mathieson et al., 2009; Van Houtte, Van Lierde, & Claeys,
2011). Although there is no internationally accepted classifi-
cation system, endoscopic assessment typically reveals con-
striction of the laryngeal mechanism in one or more of the
following ways: (a) anterior–posterior constriction of the
vocal folds, (b) lateral–medial constriction of the vocal folds,
and/or (c) approximation of the ventricular or false vocal
folds. When severe enough, a sphincter-like closure of the
entire larynx occurs (Rubin, Sataloff, & Korovin, 2006).
MTD, whether primary or secondary, alters phona-
tory airflow substantially. It would be simplest if increased
“tension” equaled vocal fold hyperadduction, increased
laryngeal resistance to airflow (Rlaw), and decreased pho-
natory airflow, but this is not the universal case. Higgins,
Chait, and Schulte (1999) reported large interparticipant
variations in aerodynamic characteristics of individuals with
primary and secondary MTD. Five aerodynamic profiles
were recently identified in women with primary MTD as
compared to women with normal voices (Gillespie, Gartner-
Schmidt, Rubinstein, & Abbott, 2013). These profiles were
(a) normal flow, normal estimated subglottic pressure
(est-Psub); (b) high flow, high est-Psub; (c) low flow, normal
est-Psub; (d) normal flow, high est-Psub; and (e) high flow,
normal est-Psub. Estimated subglottic pressure can increase
as Rlaw increases. It is not feasible to establish a one-to-one
correlation between phonatory airflow and a particular
pattern of laryngeal constriction/hyperfunction.
Voice therapy is considered the primary choice of
treatment for improving the perceptually abnormal voice
caused by primary or secondary MTD (Roy, 2008). The
goal of voice therapy is to bring about relaxation of the in-
effectively tensed musculature and improve vocal quality.
Various muscle “rebalancing” approaches and research data
supporting their use have been proposed over the years. Some
of these include vocal function exercises (Stemple, Glaze, &
Gerdeman, 2000), resonant voice therapy (Verdolini-Marston,
Burke, Lessac, Glaze, & Caldwell, 1995), the accent method
(Kotby, 1995), voice facilitating approaches (Boone et al.,
2013), and circumlaryngeal massage (Roy, Ford, & Bless,
1996; Roy & Leeper, 1993). One treatment method that has
been used in voice clinics is the flow phonation method, ini-
tially proposed by Stone and Casteel (1982). Flow phonation
emphasizes the channeling of the airstream using a slightly
abducted laryngeal position, which eventually facilitates clear
vocal quality. The approach uses exercises, such as blowing
bubbles in a cup of water, gargling, and blowing air into tis-
sue paper, to facilitate airflow through a relaxed, balanced,
and open vocal tract (Gartner-Schmidt, 2010; Stone & Casteel,
1982). Variants of these exercises have been used with reported
clinical success (Gartner-Schmidt, 2010). McCullough et al.
(2012) recently provided the first data-based study of this
method’s utility for improving airflow and decreasing symp-
toms of vocal hyperfunction. The authors reported data
from six participants who were treated for primary MTD
using flow phonation exercises for a 6-week period. Patients
were assessed on acoustic and perceptual measures as well
as the Voice Handicap Index (Jacobson et al., 1997) before
and after treatment. A Phonatory Aerodynamic System
(PAS; KayPENTAX) was also used to measure phonatory
airflow (i.e., flow of air through the larynx during phona-
tion) and Rlaw, which is resistance to the flow of air at the
level of the vocal folds, before and after treatment as well
as in every therapy session. In addition to improvements in
perceptual and acoustic measures of voicing and voice
handicap ratings, most of the patients with primary MTD
who completed the flow phonation exercise protocol de-
creased Rlaw values (i.e., laryngeal resistance) and increased
phonatory airflow. Given the apparent utility of this method
in alleviating vocal signs and symptoms, as demonstrated
by McCullough et al., it is of interest to determine if the
same method can be used with a telepractice delivery
model. The current investigation served to determine the
utility of telepractice for providing this type of treatment to
individuals with primary MTD.
With the prevalence of a disorder such as MTD, mil-
lions of people are affected. For example, Cohen, Kim, Roy,
Asche, and Courey (2012b) reported about 536,943 individ-
uals among 55 million individuals in a national database of
patients treated by primary care physicians and otolaryngolo-
gists received a diagnosis of dysphonia. In a similar studywith the same database, Cohen, Kim, Roy, Asche, and
Courey (2012a) reported that nearly three fourths of the
population with a diagnosis of dysphonia were referred for
medical treatment across a 12-month period. MTD is a
significant cause of dysphonia. Data from various studies
(Roy, 2003; Sama, Carding, Price, Kelly, & Wilson, 2001)
indicate that the caseload of primary MTD in voice clinics
can range from 40% to 60%, implying that it is one of the
most common voice disorders seen in voice clinics. Outside
of regional voice clinics, this type of treatment may not be
available. Patients currently requiring voice treatment often
travel long distances to metropolitan areas with more ad-
vanced rehabilitation facilities. Traveling two or three times
per week for treatment imposes great hardships. Develop-
ing a way to provide treatment to such patients closer to
home could greatly improve quality of care and quality of
life, reducing the burdens imposed by time off from work
and costs of travel. A high percentage of people (65%) are
reported to drop out of voice treatment (Hapner, Portone-
Maira, & Johns, 2009). The interval between voice therapy
referral and scheduling voice therapy has been reported
as an important variable affecting adherence to voice therapy
(Portone-Maira, Wise, Johns, & Hapner, 2011). Teleprac-
tice will offer an opportunity to decrease this time interval
for individuals who do not have easier access to clinics,
thereby reducing dropout from treatment (Tindall, 2012).
Moreover, telepractice provides a “greener” method for
treating patients. Less travel means reductions in greenhouse
gases and smaller carbon footprints on the planet (Masino,
Rubinstein, Lem, Purdy, & Rossos, 2010).
Telepractice offers the potential to extend clinical
services to remote, rural, and underserved populations and
to culturally and linguistically diverse populations as well.
A health care survey of speech-language pathologists across
health care settings conducted by ASHA in 2009 indicated
that 25% of the respondents had unfilled positions in their
facility. The highest percentage of vacancies (36%) was in
home health (ASHA, 2009). Although the rate of reported
vacancies of speech-language pathologists in health care
has decreased from its high of 40% in 2005 (ASHA,
2005), shortages are most likely to be felt in rural and un-
derserved areas. Telepractice offers one solution to all
these issues. Although the need for telepractice has been real-
ized, actual clinical practice is relatively sparse. An ASHA
survey (2002) reported that only 2% of 1,667 professionals
who participated in the survey were actively involved in re-
search or clinical care using telepractice. This number has
certainly improved over the past decade, but there is a need
to develop, validate, and promote assessment/treatment pro-
tocols for telepractice. Therefore, this study was conducted
with the primary objective of determining the utility of tele-
practice for delivering the flow phonation voice treatment
method to individuals with primary MTD. We hypothesized
that patients treated via telepractice would demonstrate im-
provements in phonatory airflow and Rlaw as well as im-
provements in acoustic and perceptual measures and voice
handicap equivalent to those receiving in-person evaluation
and treatment.
Method
The study had a prospective randomized control de-
sign. Randomization was done to eliminate bias and con-
founding in treatment assignment. Fourteen (11 women,
three men) participants (see Table 1) were evaluated in per-
son at an outpatient voice and swallowing clinic of a uni-
versity medical center and were randomly assigned, via a
computer-generated random numbers table, to receive treat-
ment either in person or via telepractice at an affiliated out-
reach facility. The participants were 16 years and older and
presented with “muscle tension dysphonia” documented in
their medical record by an otolaryngologist, as discussed
shortly. All participants had primary MTD, and those who
presented with organic vocal lesions, head and neck cancer,
spasmodic dysphonia or other neurological disorders, respi-
ratory disorders including asthma, or oropharyngeal dyspha-
gia were excluded from the study. In addition, participants
who used other voice therapy methods at a different facility
or pharmacological treatment (other than proton pump in-
hibitors recommended for disorders of laryngopharyngeal
reflux–related symptoms) for the voice problem were excluded
from the study. Baseline characteristics of the participants
are reported in Table 2. The study was approved by the
medical center’s institutional review board, and all partici-
pants provided written informed consent.Procedures
Assessment
Laryngoscopic assessment. Laryngoscopic assessment
was performed either by the study otolaryngologist (the
fifth author) or the first author. A flexible naso-endoscope
was inserted into one of the nares, depending on patient
preference, after application of topical anesthesia (0.2 ml
viscous lidocaine delivered on cotton-tip applicator).
Once a clear image of the larynx was obtained, the patient
was asked to sustain /i/ for at least 3 s at his or her mostTable 1. Demographic characteristics of study participants.
Participant Age Gender Group Occupation
TVS001 53 F Telepractice College professor
TVS002 81 M In person Retired real estate agent
TVS003 56 F Telepractice Retired teacher
TVS006 57 M In person Real estate agent
TVS011 33 F In person Business manager
TVS014 56 F Telepractice Part-time real estate age
TVS015 59 F In person Radio and media
TVS016 39 F Telepractice Business manager
TVS018 51 F Telepractice Nurse
TVS021 60 F In person Unemployed during the
assessment; previous
TVS022 59 F Telepractice Nurse
TVS023 16 F In person School student
TVS024 60 F Telepractice Retired teacher
TVS026 32 M In person Business manager
Note. F = female; M = male.comfortable speaking pitch and loudness as well as at his or
her lowest pitch and highest pitch, increasing and decreasing
loudness generically. Vocal fold function and anatomy
were examined in regular halogen mode and with stroboscopy.
The otolaryngologist and the first author reviewed video-
stroboscopic examinations to ensure proper fit with require-
ments of primary MTD. MTD was defined visually as
one of the four types described by Rubin et al. (2006) and
further characterized according to criteria established by
Koufman and Blalock (1982); that is, laryngoscopic studies
for each patient were examined for the presence of lateral–
medial compression, anterior–posterior compression, and
ventricular adduction/supraglottic compression. Lateral–
medial compression was identified as hyperadduction of the
vocal folds in the lateral medial axis. Anterior–posterior
compression was identified as constriction of the vocal
tract at the level of the laryngeal vestibule in the anterior–
posterior axis. Ventricular adduction/supraglottic com-
pression was identified as supraglottic muscle activity,
including partial or complete adduction of false vocal folds.
All the participants presented with at least one of these
findings. Patients with organic conditions were excluded.
The otolaryngologist and a speech-language pathologist
arrived at a consensus on the presence of MTD through
running discussions.
Auditory–perceptual assessment. Assessment proce-
dures were carried out within 2 weeks of an established di-
agnosis. Auditory–perceptual assessment was conducted
using the Consensus Auditory Perceptual Evaluation of
Voice (CAPE-V; Kempster, Gerratt, Verdolini Abbott,
Barkmeier-Kramer, & Hillman, 2009; Zraick et al., 2011).
This assessment provides a measure of the clinician’s per-
ceptual ratings of a patient’s voice on a variety of parame-
ters, including breathiness, roughness, strain, pitch, loudness,
and overall severity. Voice samples consisted of sustained /a/
and /i/ for at least 3 s, reading of six sentences, and spontane-
ous speech. All voice samples were rated at the beginning
and the end of treatment by a speech-language pathologistDays post-onset
of symptoms Additional information
4 months —
4 months —
3 months Prior history of thyroidectomy
4 months Medications for reflux symptoms
1 month —
nt 2 years —
5 months —
2 months Medications for reflux symptoms
1 month —
initial
ly a clerk
3 years —
3 months Occasional shortness of breath
8 months —
1 year —
2 months —
Table 2. Baseline characteristics of study participants.
Participant Groupa NHR VTI Mean Airflow in CSP Mean Airflow in MSP Rlaw VHI CAPE-V severity
TVS001 1 0.150 0.017 0.09 0.10 41.47 36 25
TVS002 2 0.172 0.056 0.26 0.25 9.42 35 27
TVS003 1 0.151 0.046 0.37 0.34 10.53 16 18
TVS006 2 0.136 0.047 1.28 1.20 15.04 29 36
TVS011 2 0.122 0.033 0.22 0.19 50.80 22 28
TVS014 1 0.628 0.166 0.09 0.11 51.73 78 35
TVS015 2 0.144 0.067 0.28 0.20 46.32 19 25
TVS016 1 0.183 0.052 0.29 0.32 30.22 28 22
TVS018 1 0.148 0.045 0.09 0.10 55.70 20 26
TVS021 2 0.541 0.129 0.23 0.12 923.82 111 61
TVS022 1 0.164 0.034 0.09 0.07 53.06 62 33
TVS023b 2 114 100
TVS024 1 0.131 0.070 0.27 0.24 124.38 27 8
TVS026 2 0.150 0.039 0.26 0.19 11.76 40 18
Note. NHR = noise-to-harmonic ratio; VTI = voice turbulence index; CSP = comfortable sustained phonation; MSP = maximum sustained
phonation; Rlaw = laryngeal resistance; VHI = Voice Handicap Index; CAPE-V = Consensus Auditory Perceptual Evaluation of Voice.
aGroup 1 = telepractice, Group 2 = in person. bThe patient was aphonic; therefore, measures were not recorded.(the second author), and then 10% of the data were rerated
blindly in random order by two other speech-language pa-
thologists (the fourth author and another speech-language
pathologist), both with extensive experience in evaluation
of voice disorders. Pre- and posttreatment ratings for each
participant were made together, and the conditions of time
point and participant information were blinded; that is, pre-
and posttreatment samples of each participant’s voice were
provided to each rater with order of occurrence randomized.
Thus, each rater had two samples to rate without the knowl-
edge of whether they had been obtained prior to or after
treatment. Only the overall severity measure was considered
for analysis purposes.
Acoustic assessment. Acoustic measures were made
from recordings on the KayPENTAX Computerized
Speech Lab 4500 (KayPENTAX, Inc.) in a room with
nominal ambient noise. The default calibration settings of
the Computerized Speech Lab Model 4500 were used,
and the microphone (Shure SM48) was kept at a consistent
distance of approximately 6 in. from the speaker’s mouth.
For the multidimensional voice profile analysis, the voice
sample consisted of an /a/ vowel sustained for 5 s, which
was then analyzed for noise-to-harmonic ratio (NHR),
voice turbulence index (VTI), and frequency and intensity
perturbation measures. NHR has been demonstrated to
correlate well with perceptual roughness (Bhuta, Patrick, &
Garnett, 2004; de Krom, 1995), whereas VTI represents
the turbulence caused by incomplete adduction of the vocal
folds (Di Nicola, Fiorella, Spinelli, & Fiorella, 2006).
Aerodynamic measurement. Aerodynamic assessment
of phonatory airflow and Rlaw were derived using the PAS
Model 6600 (KayPENTAX). The following tasks were
conducted:
(a) Maximum sustained phonation (MSP): Participants
were instructed to take a deep breath, then to produce
a sustained open vowel (/a/) at a comfortable pitchand loudness for as long as they could sustain voicing
in one breath.
(b) Comfortable sustained phonation (CSP): Participants
were instructed to take a deep breath, then to produce
a sustained open vowel (/a/) at a comfortable pitch
and loudness for at least 5 s once data capture was
initiated.
(c) Voicing efficiency: Participants were instructed to
repeat the voiced vowel /a/ and the voiceless stop
plosive /p/ nine times in vowel/consonant format (i.e.,
/apapapapapapapa/), placing equal stress on each
syllable as described by Zraick, Smith-Olinde, and
Shotts (2012). To ensure consistent rhythm, participants
were trained on the speaking task until they produced
the syllable trains evenly and at a comfortable loudness
level.
Three trials of each of the foregoing tasks were con-
ducted, and the average of the three trials was used for analy-
sis. Participants were provided with instructions for each
task before every trial. Mean phonatory airflow (liters per
second) was derived from CSP and MSP tasks individually.
CSP protocol is based on analysis of a sustained portion
of voicing that is comfortable in pitch and loudness for the
participant. We were, however, interested in the total expi-
ratory volume and phonation time as well, and therefore
the MSP protocol was also used. Estimates of subglottal
pressure, mean phonatory sound pressure level, Rlaw
and phonatory airflow were derived from the voicing effi-
ciency task. Measures of average peak (intraoral) air pres-
sure during adjacent productions of the consonant /p/
(across syllables 2–8) provided the estimate of subglottal
pressure (Zraick et al., 2012). Mean airflow during voic-
ing was derived from the oral airflow measures during
the vowel segments. Two measures (peak air pressure and
mean airflow during voicing) were subsequently used by
the PAS software to calculate Rlaw value, which is defined
as the ratio of peak pressure/airflow. The airflow signal
was examined to ensure a baseline (zero) was reached for
each pressure peak so as to not underestimate subglottic
pressure.
Patient perception. All participants completed the
30-item Voice Handicap Index before and after the treat-
ment. This provided the patient perceptions of the handicap-
ping effects of their voice.
Treatment
Participants were randomly assigned to one of two
groups. The random assignment of participants was car-
ried out after the assessment session before initiation of
any treatment. Participants in Group 1 received treatment
in person at the medical center. Participants in Group 2
received treatment at one of 13 regional affiliated satellite
clinics through an Internet protocol–based videoconferenc-
ing system supported by a Tandberg interactive audio–
video unit. The farthest satellite clinic was 190 miles from
the on-site clinic, and the closest was 1 mile. Participants
in Group 2 traveled not more than 15 miles to the satellite
clinic. Participants in Group 2 signed an additional form
granting permission to be photographed and video recorded.
The clinician worked with the patient from the host medical
center. The participants in both groups attended 12 sessions
of voice therapy across 6 weeks (two sessions per week). The
number of sessions was initially established considering re-
imbursement that is currently available for speech-language
therapy. Also, because each patient differs in terms of base-
lines, compliance, and general attitudes toward treatment, it
is difficult to determine a specific number of sessions to be the
standard for all patients. Six weeks of treatment have been
targeted in previous studies on voice therapy (MacKenzie,
Millar, Wilson, Sellars, & Deary, 2001). McCrory (2001)
conducted a retrospective audit of various parameters de-
fining best practice in voice therapy and reported an av-
erage of two to 12 sessions of therapy for vocal fold nodules.
Lockhart, Paton, and Pearson (1997) reported the average
number of treatment sessions for vocal strain was two to
14 and about two to 15 for ventricular fold overaction in
two different voice centers. Considering these factors, a uni-
form number of 12 sessions for all patients was determined.
Additional research into the average number of treatment
sessions necessary for varying pathologies and patterns of
baseline measures is underway. All treatment sessions were
conducted by the first author, who was, at the time, a doc-
toral student in communication sciences and disorders with a
focus in voice disorders and dysphagia and with about 4 years’
clinical experience in voice care.
Part I: Vocal Hygiene (Approximately 10–15 Min)
The protocol established by Nanjundeswaran et al.
(2012) was used for vocal hygiene education. In Session 1,
each participant completed a vocal hygiene questionnaire,
which was reviewed with the participant. Participants were
then provided instructions for improving vocal hygieneon the basis of their responses to the questionnaire. Vocal
hygiene instructions included information on intake of ap-
propriate fluids (noncaffeinated), controlled use of voice,
and control of reflux or allergies if applicable. Recommen-
dations were discussed, and problem areas were highlighted
for each participant on the basis of clinical judgment. In
each of the additional 11 sessions, participants conveyed
the vocal hygiene instructions back to the clinician and
discussed successes and problem areas since the previous
session.
Part II: Airflow Exercises (Flow Phonation; 20–25 Min
per Session)
Each treatment session typically used two of three
airflow exercises: gargling, cup bubble blowing, and stretch
and flow phonation, depending on the participant’s success
with each exercise. Each exercise uses a built-in form of
biofeedback (water or tissue) and the same basic progres-
sion of activities: (a) airflow task without voicing to establish
positive airflow; (b) adding voicing to the task; (c) moving
up and down the pitch range during the voicing task; and
(d) moving to a speaking/voicing task, removing biofeedback.
During each vocalization attempt, the clinician listened for
a clear and effortless vocal quality and trained the partici-
pant to listen and feel relaxation within the throat.
In greater detail, the gargling exercise required the
participant to place a small amount of water in the mouth,
recline the head, and gargle without voice 10 times for 5–6 s
with breaks in between. The participant was instructed to
relax the throat and gargle with enough airflow to make the
bubbles pop up out of the mouth. After this was accom-
plished, the next step was to gargle the same way but with
voice—again ensuring bubbles popped up out of the mouth.
The third step was to gargle with the head back with the
voice moving up and down pitch scales freely and relaxed.
This was done 10 times as well. The fourth step began with
the participant gargling with voice and then rolling the head
forward while gargling, closing the mouth, and allowing
the sound to come out the nares into a hum. The partici-
pant then swallowed the water, took an easy breath, and
repeated “mmmmama mama,” “mmmmay, may, may, may,”
and then continued with /m/ and other vowels. When voicing
sounded sufficiently relaxed without laryngeal tension, it was
carried over into words, such asmamma,marry,many,maybe,
marble. This method was used to transition voice with gar-
gling into voice without gargling and on into a more natural
pattern of voice use. The focus was not about nasal sounds
or frontal focus as much as moving the hum, which occurred
from the head roll, into speech.
The cup bubble blowing exercise required the partici-
pant to take a clear plastic cup of water filled about two
thirds of the way up, place the mouth over the cup, and
tip it up until the top lip was in the water. The participant
drew in a breath and blew bubbles without using voice,
again to establish positive airflow. Bubbles were supposed
to be actively popping up from the cup. This was done
10 times, and then voicing was added for 10 trials to make
a “motorboat” sound. When voicing was added, bubbles
were to remain as active as they were without the voice.
In the third step, the participant blew bubbles with voice
moving freely and relaxed up and down in pitch. In the
fourth step, the participant began by blowing bubbles with
the voice and then slowly pulled the cup away from the
mouth. As the cup was pulled away, the participant main-
tained pursed lips and continued voicing with a relaxed,
breathy “oooh.” This step was repeated 10 times. For all
the trials, the clinician provided feedback on vocal quality
and perceived relaxation in the voice.
The final exercise involved stretch and flow phona-
tion. For this exercise, the participant took a piece of tissue
paper, separated the layers, and folded one layer in half.
The tissue was held between the index and middle fingers
near the top of the tissue, and the tissue was held in front
of the face hanging where the mouth is centered. In the
first part of the exercise, the participant blew air into the
tissue such that the tissue moved back parallel to the floor
for 4–5 s. This was done 10 times with breaks in between.
Then the participant began as in Step 1, blowing air into
the tissue. When the tissue was parallel to the floor, the
participant added voice. The tissue was to remain parallel
to the floor, so the voice would be very breathy. This was
done 10 times with sufficient breaks. In Step 3, the par-
ticipant began blowing air into the tissue and voicing simul-
taneously, ensuring it was parallel to the floor, and then
said “one” with the same easy, breathy voice. This was
repeated for numbers 2, 3, and so forth, up to 10. The
fourth step was done the same way but with “H” and “WH”
initiated phrases rather than words (i.e., “How are you?”
“What time is it?”).
Participants started with gargling and cup bubble
blowing. As they mastered one or both of these exercises,
they were moved into stretch and flow exercises, typically
in the fifth session for 13 patients and the seventh session
for one patient who took longer to master relaxation with
the former exercises. The sessions, including vocal hygiene
reviews and voice work, typically lasted for about 45 min.
Telepractice Component
A hybrid approach was used in the telepractice group;
that is, all the participants were evaluated in person during
the pre- and posttreatment sessions, but treatment was
delivered using telepractice. Because the primary aim of the
study was to determine the use of telepractice for a thera-
peutic activity and because participants were not random-
ized to the groups until after initial assessment, pre- and
posttreatment evaluations were carried out in person. The
treatment was delivered using a Tandberg interactive
video–audio unit. As noted earlier, all sessions for both
groups of participants were delivered by one clinician (the
first author). Care was taken to ensure a quiet environ-
ment, and confirmation was sought from participants to
ensure they could see and hear the clinician before each
session was begun. The clinician also made sure the posi-
tioning of the participant was appropriate for adequate
visualization of breathing patterns, and assessment of eachtreatment exercise. Support staff in each center ensured
that the camera and microphone were positioned appro-
priately. Staff also provided materials needed for treatment,
such as a clear cup, water, and tissue papers. Information
technology support staff were accessible for all 12 treatment
sessions for each participant in case of technical difficul-
ties. There was one instance of a delayed connection during
the sixth session for Participant TVS022 and another in-
stance of poor audio and reverberation in the first session
for Participant TVS003. The information technology sup-
port staff resolved these issues quickly. The treatment was
delivered the same way for both in-person and telepractice
groups.
All 14 participants completed the entire research
protocol. All 14 participants underwent a pretreatment
assessment within 2 weeks of a diagnosis of MTD and a
posttreatment assessment within 5 days of completion
of treatment.
Statistical Analysis of Data
Acoustic measures of VTI and NHR, aerodynamic
measures of mean airflow during CSP and MSP tasks,
aerodynamic resistance, overall severity of voice quality as
measured by the CAPE-V, and the total Voice Handicap
Index score were subjected to separate statistical analyses
using SPSS Version 20. In an ideal situation, we would
have performed two-way analyses of variance for within-
participant (time point) and between-participant (treat-
ment delivery mode) variables. However, our sample size of
only seven per group would have posed threats to interpre-
tation of the data. The likelihood of both underpowered
analyses and violations of fundamental assumptions of the
distribution of the data was high, and therefore nonpara-
metric analyses were performed as follows.
Analysis 1: Telepractice Versus In Person
To analyze the outcome of treatment across the two
groups, a change variable was first derived. For example,
ChangeNHR was calculated by subtracting posttreatment
NHR values from pretreatment NHR values (NHRPre −
NHRPost). A change variable was similarly obtained for
all acoustic, aerodynamic, auditory–perceptual, and self-
perception of voice handicap measures. The change vari-
able of each measure was then subjected to Mann–Whitney
U test to examine if a change in a variable as an effect of
treatment is comparable across the two treatment delivery
modes.
Analysis 2: Pretreatment Versus Posttreatment
The Wilcoxon signed-ranks test was performed to ex-
amine the magnitude and significance of changes in out-
come measures after treatment. Actual pretreatment and
posttreatment measures (and not change in a measure) were
compared across the two time points. Additionally, Cohen’s
d measures as part of effect sizes of treatment were com-
puted. Marginal means of change in outcome measures
from before versus after treatment were also calculated.
Results
Reliability of Perceptual Voice Ratings
The data corpus was rated for vocal quality by the
second author, and 10% of the data were rerated by two
other speech-language pathologists (the fourth author and
another speech-language pathologist) on the basis of audio
recordings using the CAPE-V, which in turn uses a 100-mm
visual analog scale. Pre- and posttreatment samples of
each participant’s voice were provided to each rater with
order of occurrence randomized. Thus, each rater had
two samples to listen to and rate without the knowledge of
whether it had been obtained prior to or after treatment.
The .nsp files obtained from the CSL program were con-
verted to wave files (.wav) and were presented through a
computer program (Windows 7 Media Player) through
high-fidelity headphones. The judges completed voice qual-
ity ratings in one session. Because the data are continuous,
intraclass correlations were calculated to measure interrater
reliability of ratings. Intraclass correlation values for overall
severity were high, on the order of .92 for pretreatment
samples and .84 for posttreatment samples, demonstrating a
strong interrater reliability of ratings.Telepractice Versus in Person (Across Groups)
The Mann–Whitney U test indicated that outcome
measures for change in CAPE-V overall severity (U = 15,
p = .62), change in NHR (U = 14, p = .21), change in VTI
(U = 19, p = .84), change in mean airflow for MSP (U =
8.5, p = .073), change in mean airflow for CSP (U = 11,
p = .181), change in Rlaw (U = 11, p = .181), and change
in Voice Handicap Index scores (U = 20, p = .259) did not
differ significantly between the groups (see Table 3). This
is further depicted in Figures 1–5, which demonstrate the
direction of change of marginal means in the two groups
from pretreatment to posttreatment. Graphical depictions
of the data (see Figures 1–5) indicate that effects of treat-
ment on both groups appear visually comparable, and most
changes posttreatment occurred in the same direction be-
tween in-person and telepractice groups (see Figures 1–5).
The one exception was mean airflow for voicing (see Fig-
ure 4). Mean airflow during MSP and CSP tasks increased
as an effect of treatment in the telepractice group and de-
creased as an effect of treatment in the in-person group,
although the change was not statistically significant.Table 3. Results of a Mann–Whitney U test for auditory–perceptual, acous
(telepractice vs. in person).
Change in
CAPE-V severity
Change
in NHR
Change
in VTI
Change in m
airflow in C
U = 15 U = 14 U = 19 U = 11
p = .620 p = .209 p = .836 p = .181
Note. CAPE-V = Consensus Auditory Perceptual Evaluation of Voice; NH
comfortable sustained phonation; MSP = maximum sustained phonation;Pretreatment Versus Posttreatment (Across Time Points)
The Wilcoxon signed-ranks test yielded statistically
significant improvements in the CAPE-V (clinician percep-
tion of severity; Z = 3.30, p = .001), Voice Handicap Index
(patient perception of handicap; Z = 3.17, p = .002), pre-
to posttherapy, and some aerodynamic measures: mean
airflow during CSP (Z = 2.04, p = .04) and MSP (Z =
2.12, p = .034), on the basis of norms reported by Zraick
et al. (2011; see Table 4). Changes in acoustic measures of
NHR (Z = 1.92, p = .055) and VTI (Z = 1.78, p = .075)
and the aerodynamic measure of laryngeal airway resis-
tance (Rlaw; Z = 1.01, p = .311) moved in the same di-
rection of a therapeutic effect pre- to posttherapy (see
Figures 1–5) for the in-person and telepractice groups,
demonstrating clinical improvement, but did not reach sta-
tistical significance. In addition, Cohen’s d effect sizes were
computed for each outcome measure. The effect sizes for
CAPE-V severity, NHR, VTI, mean airflow in CSP, mean
airflow in MSP, Rlaw, and VHI were 1.73, 0.59, 0.82, 0.29,
0.27, 0.41 and 1.24, respectively. It is important to observe
that there were differences in baseline values of phonatory
airflow measures across participants.Discussion
The primary purpose of this study was to determine
whether flow phonation treatment for primary MTD could
be delivered equally well via telepractice and in-person
treatment. Results of across-groups comparison yielded no
significant differences, demonstrating that participants with
primary MTD enrolled randomly in telepractice sessions
performed similarly to participants enrolled in in-person
treatment. It was also important to determine whether the
treatment approaches were similarly effective or ineffective;
that is, it is possible that neither group improved, or both
did, or even got worse. Considering the across-groups
and across–time points analyses, the quality of voicing, as
judged by the clinician (CAPE-V) and the patient’s percep-
tion of handicap (Voice Handicap Index) improved, again,
irrespective of the treatment delivery mode. The majority
of participants also improved on acoustic and aerodynamic
measures regardless of the method of delivery, although
improvements were not statistically significant.
These results are consistent with earlier investigations
supporting the use of telepractice in delivering voicetic, aerodynamic, and quality-of-life measures across the two groups
ean
SP
Change in mean
airflow in MSP
Change
in Rlaw
Change
in VHI
U = 8.5 U = 11 U = 20
p = .073 p = .181 p = .259
R = noise-to-harmonic ratio; VTI = voice turbulence index; CSP =
Rlaw = laryngeal resistance; VHI = Voice Handicap Index.
Figure 1. Marginal means of the Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) severity for the treatment groups at two time
points 1 and 2 (pre- and posttreatment, respectively).therapy. To be specific, the results are in general agreement
with those from studies by Mashima et al. (2003), Tindall
et al. (2008), and Constantinescu et al. (2010a, 2010b,
2011), all of whom reported positive outcomes of delivering
voice treatment for different pathologies through telepractice.Figure 2. Marginal means of noise-to-harmonic ratio (NHR) and voice tu
treatment groups at two time points (pre- and posttreatment). The y-axis hIt is important to clarify the types of treatment used when in-
vestigating telepractice given that telepractice is not a treat-
ment but rather a method of delivering treatment. Different
treatments may be more suited for telepractice than others.
Although it may not be necessary to provide data supportingrbulence index (VTI) from multidimensional voice profile for the
as no units because the measures indicate a ratio.
Figure 3. Marginal means for laryngeal resistance for the treatment groups at two time points (pre- and posttreatment).every type of voice therapy for use with telepractice, a
relatively small number of studies using voice treatments
have been published, and thus far, none have dealt with MTD.
The current data support the use of telepractice for deliv-
ering voice therapy for treating primary MTD with flowFigure 4. Marginal means of mean airflow during comfortable (CSP) and
two time points (pre- and posttreatment). sec = second.phonation exercises. The impact of the results of this study
could be very positive for many individuals who suffer this
disorder and might not otherwise receive adequate care for
the problem. The goal of the speech-language pathologist
is to maximize functional abilities and promote quality ofmaximum (MSP) sustained phonation for the treatment groups at
Figure 5. Marginal means for ratings on the Voice Handicap Index (VHI) for the treatment groups at two time points (pre- and posttreatment).life for individuals with communication disorders. Some in-
dividuals live in rural, underserved areas far from a medi-
cal center or a health facility that offers speech pathology
services. Others have physical impairments (e.g., mo-
bility issues) that prevent them from going somewhere to
receive treatment. Still others may have no means of trans-
portation. Telepractice is one tool that may help reach such
individuals, and the results of this study suggest that tele-
practice can, for certain disorders and treatments, be as
beneficial as treating patients for their vocal symptoms in
person. Moreover, it can reduce or eliminate travel time
and inconveniences associated with travel as well as costs,
and it provides a “greener” option for those who live far
away, with less of a negative impact on our planet.
The results also shed some light on specific outcomes of
the flow phonation exercises and why a benefit was observed.
Phonatory airflow is often decreased when laryngeal tensionTable 4. Results of a Wilcoxon signed-ranks test for auditory–perceptual,
time points (pre- and posttreatment).
CAPE-V severity NHR VTI Mean airflow in
Z = −3.297 Z = −1.922 Z = −1.779 Z = −2.040
p = .001* p = .055** p = .075** p = .041*
Note. CAPE-V = Consensus Auditory Perceptual Evaluation of Voice; NH
comfortable sustained phonation; MSP = maximum sustained phonation;
*p < .05. **Approaching significance at p < .05.creates a constriction of the glottis. Reducing the tension
should then open the glottis and allow for increased phona-
tory airflow. Phonatory airflow might also be increased in
some patients with MTD because tension, especially anterior–
posterior tension, may inhibit glottal closure. Thus, when air-
flow is too high, normalization would mean that it is reduced.
When airflow is too low normalization would mean it is in-
creased. Phonatory airflow increased more in the telepractice
group than the in-person group, but individuals in the in-
person group started with a higher mean phonatory airflow,
indicating less of a need to increase it. The difference in this
particular measure, therefore, does not indicate one group
did better than the other but rather that the groups had some
differences in the effects of putative muscle tension on the co-
ordination of the respiratory and phonatory systems. This
premise has been documented in studies by Higgins et al.
(1999) and Gillespie et al. (2013), who have reported wideacoustic, aerodynamic, and quality-of-life measures across the two
CSP Mean airflow in MSP Rlaw VHI
Z = −2.119 Z = −1.013 Z = −3.170
p = .034* p = .311 p = .002*
R = noise-to-harmonic ratio; VTI = voice turbulence index; CSP =
Rlaw = laryngeal resistance; VHI = Voice Handicap Index.
variability in aerodynamic characteristics in participants with
MTD and different aerodynamic subtypes in participants
with primary MTD, respectively. The fact that all patients
improved on perceptual measures of voice by the clinician as
well as self-perceived voice handicap indicate the direction
and amount of the changes in airflow were likely beneficial.
This method of treatment was designed to increase airflow
in patients with severely limited flow of air, but our results
suggest it may also be beneficial for patients with some-
what greater airflow initially. A closer examination of Rlaw
could shed additional light on these findings, although dif-
ferences in Rlaw were present before treatment across the
two groups in our study, limiting further interpretation.
Additional research should be conducted to determine
whether levels of airflow and Rlaw may predict who would
benefit most from this treatment method.
It is important to note that these findings are specific
to primary MTD alone. As noted earlier, primary MTD
is a stand-alone laryngeal tension abnormality causing
changes to Rlaw and consequently airflow. The patterns of
airflow and Rlaw impairments could be significantly differ-
ent in cases of secondary MTD that are concurrent with
another physical impairment, such as spasmodic dyspho-
nia or laryngopharyngeal reflux disorders. Therefore, the
results have to be interpreted in view of primary MTD
alone.
There are a number of weaknesses in this study. Our
sample size was particularly small. We determined sam-
ple size on the basis of statistical results from pilot data
(McCullough et al., 2012), but those data were focused on
the exercises themselves and not the use of telehealth tech-
nology. As stated, larger numbers guided by detailed power
analyses are needed to more critically examine different
types of MTD and changes in Rlaw in relation to phona-
tory airflow and tease out the effects of initial severity.
More data are needed and are in progress on dose response
as 12 sessions may be necessary for some whereas only six
or fewer may be necessary for others. Procedural reliability
was not measured in our study. Although only one clinician
conducted all treatment sessions for all the study partici-
pants, it would have been useful to ensure uniformity of
treatment by objective procedural fidelity reports. Percent-
age agreement could have been a better measure to report
reliability of auditory perceptual measures. We used intra-
class correlations, which may not reflect best estimates of
interjudge reliability for perceptual analysis of voice in par-
ticular (Kreiman, Gerratt, Kempster, Erman, & Berke,
1993). Treatment compliance was generally quite strong,
but data regarding some variations are currently being
analyzed. We also used change scores as a dependent vari-
able for our analyses. The use of normalized raw scores
may have altered or assisted with interpretation to some de-
gree. An important aspect that could have offered clearer
insights into the results is the differences in baseline values
of various airflow measures. Although control for partici-
pant selection bias was exercised using randomization, it
also led to heterogeneity across the groups with respect to
airflow measures. Future randomized controlled studieson treatment issues such as this should ensure some sort of
stratification on the basis of baseline severity.Conclusions
The specific aim of this study was to explore the use
of telepractice in delivering flow phonation exercises for
primary MTD. MTD is one of the most common behavioral
voice disorders seen in clinics, and data supporting the use
of telepractice for providing behavioral interventions to
individuals with this form of dysphonia are scarce. These
data support the use of telepractice to deliver this treat-
ment successfully and may improve patient care by provid-
ing treatment to underserved individuals in rural or other
populations without the ability to come to medical centers
where such treatment is available.Acknowledgments
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